Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Enemy at the Gates: The Emerging Threat of COVID-19

Philip Seo, MD, MHS  |  Issue: April 2020  |  March 23, 2020

These guidelines acknowledge an important limitation of the healthcare system that is difficult to understand if you have never worked in a hospital: ICU beds. If you have never worked in a hospital, you may imagine a hospital works like a movie theater, waiting for patrons to fill its seats. If you have worked in a hospital, you know that healthcare economics have pushed our hospitals to capacity. Our ICUs, in particular, are already filled with critically ill patients; if those numbers double in the next several months, we may have nowhere to put those patients. In the past month, we have heard much about the challenges associated with ramping up the production of N95 masks and other critical supplies. Those challenges are dwarfed by the complexities associated with creating new ICU beds, and training the staff needed to attend to those beds.

How, precisely, patients who require immunosuppression may be affected by COVID-19 is hard to say. Investigators at the University of North Carolina at Chapel Hill and the Icahn School of Medicine at Mt. Sinai, New York, have taken the first stab at trying to define the risk among immunosuppressed patients by creating a registry for patients with inflammatory bowel disease who have been infected with COVID-19.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

The Secure-IBD Registry collects basic information on patient epidemiology, co-morbid conditions and immunosuppression; because it has a head start, this group may provide us with the first glimpse into how our immunosuppressed patients may fare. But we rheumatologists are hard on their heels. An effort to create a similar registry for patients with rheumatic disease is being spearheaded by Philip Robinson, a rheumatologist and associate professor at the University of Queensland, Australia, and Jinoos Yazdany, chief of the Division of Rheumatology at Zuckerberg San Francisco General Hospital and the Alice Betts Endowed Professor of Medicine at the University of California, San Francisco, with the support of the ACR.

Social Distancing

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Basketball, in the U.S., is like a form of religion; you know things are getting serious when it affects March Madness. The National Collegiate Athletic Association’s (NCAA) Division I Basketball Tournament has been canceled. That’s as unthinkable as canceling Christmas. Major American music festivals, including South by Southwest (SXSW) and Coachella, have been cancelled or postponed. Altogether, over 25% of all Americans have been ordered to stay at home as much as possible to stem the spread of this disease.

This seems dramatic until you compare these actions to what is taking place in other countries. In Europe, Italy, Greece, France and Spain have essentially shut down their entire nations until further notice. Germany may rapidly follow suit.

Page: 1 2 3 4 5 6 | Single Page
Share: 

Filed under:ConditionsOpinionProfessional TopicsRheuminationsSpeak Out Rheum Tagged with:COVID-19Philip SeoRheuminationsSeo

Related Articles

    Rheumatology in China from Its Beginning to Today

    October 18, 2018

    Rheumatology in China is a relatively young discipline, but it has developed exponentially over the past three decades. In this article, we review the history of rheumatology in China and advances in clinical care, research and education in this field. The Founding Father Naizheng Zhang, MD, is widely regarded as the father of rheumatology in…

    Vax Hesitancy? Myths & Facts for Patients

    December 16, 2021

    Although more than 189,300,000 eligible Americans are fully vaccinated against SARS-CoV-2 as of Oct. 18, 2021, vaccine hesitancy persists.1 The U.S. Centers for Disease Control and Prevention (CDC), citing data from the U.S. Census Bureau’s Household Pulse Survey collected between May 26 and June 7, 2021, reports that in some U.S. counties—particularly in the Southeast…

    Research Helps Explain Idiosyncrasies of COVID-19

    November 23, 2021

    The Basic and Clinical Research Conference session on Rheumatology Complications of Emerging Viral Infections/SARS-CoV-2 presented findings from numerous studies that help explain some of the idiosyncrasies of COVID-19.

    Don’t Forget the Host: COVID-19 Cytokine Storm

    March 16, 2020

    The new coronavirus outbreak, COVID-19, reminds us how we have struggled to keep ahead of mutating pathogens through the ages.

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences